YZH, MM, and HL wrote the first draft
JZ: Funding acquisition, Writing review and editing
The analysis of 4887 participants treated with tirzepatide and 2,328 participants in the control groups identified 142 participants who developed at least one MACE-4p (inclusive of cardiovascular mortality, myocardial infarction, stroke, and hospitalization for unstable angina) and confirmed the cardiovascular safety with an hazard ratio (HR) of 0.80 (95% CI 0.571.11) for the comparison between tirzepatide and controls
Explore peptide therapy for Sermorelin in our overview
Note: see Appendix for an abbreviated summary of strikingly limited head-to-head RCT evidence that exist at the time of this writing Matiegka defines FFM as bone + skeletal muscle + connective tissue + organs + water
Processing a concentrated dose of vitamins and minerals takes metabolic effort, similar to the recovery your body goes through after hard exercise